Cronos vs IM Cannabis
CRON and IMCC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRON and IMCC compare
Cronos grew revenue faster over the last twelve months (55.8% versus 1.3% for IM Cannabis).
Cronos keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with −20.7% at IM Cannabis.
Cronos scores higher on the StockData Score (15 against 4 for IM Cannabis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRON | IMCC |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | – |
| Share price | $3.45 | $0.575 |
| Change, 1 year | 34.8% | −98.7% |
| Change, 5 years | −30.0% | −100.0% |
| Beta (5Y) | 0.85 | 1.36 |
| Employees | 610 | 95 |
| StockData Score | ||
| Total score | 15 (better) | 4 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 3 (better) | 2 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.3× | – |
| P/S | 6.2× | – |
| P/B | 1.2× | – |
| EV/EBITDA | 38.3× | – |
| P/FCF | 19.4× | – |
| FCF yield | 5.1% | – |
| Fair value | $3.66 | – |
| Margin of safety | 5.7% | – |
| Growth | ||
| Revenue growth (TTM) | 55.8% (better) | 1.3% |
| Revenue growth, 5Y average | 25.7% | 28.1% (better) |
| Net income growth (TTM) | 60.2% | – |
| EPS growth (TTM) | 70.0% | – |
| Profitability | ||
| Gross margin | 46.6% (better) | 17.7% |
| Operating margin | 3.4% (better) | −21.2% |
| Net margin | 28.0% (better) | −20.7% |
| FCF margin | 31.7% (better) | 8.6% |
| Return on equity | 5.4% | – |
| Return on invested capital | 2.4% (better) | −82.3% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −3.3× |
| Current ratio | 12.71 (better) | 0.56 |
| Altman Z-score | 11.97 | – |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Buyback yield | 3.7% | – |
| Shareholder yield | 3.7% | – |
| Ownership | ||
| Held by institutions | 12.9% | – |
| Held by insiders | 7.0% | 0.00% |
| Short interest, % of float | 1.2% | – |
Go deeper
- CRON stock overview
- CRON income statement
- CRON valuation and score
- IMCC stock overview
- IMCC income statement
- IMCC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.